R-loop disruption triggers irreversible topoisomerase 1–DNA cleavage complex formation during AID-dependent IgH gene diversification
Proceedings of the National Academy of Sciences · 07.04.2026 · 123 (14)
DOI: 10.1073/pnas.2533648123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 03.04.2026. Verfasst von Maki Kobayashi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyot…. Hauptthemen laut MEDLINE: DNA Topoisomerases, Type I, Cytidine Deaminase, R-Loop Structures, Immunoglobulin Class Switching. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MEXT | Japan Society for the Promotion of Science (JSPS).
Abstract (Originalsprache)
Class switch recombination (CSR) and somatic hypermutation are essential mechanisms of effective antibody production, dependent on the enzyme activation-induced cytidine deaminase (AID). Since AID lacks the intrinsic ability to cleave DNA, topoisomerase 1 (TOP1) has been hypothesized to mediate AID- and transcription-dependent DNA cleavage. However, the molecular mechanism underlying the formation of an irreversible TOP1–DNA cleavage complex (TOP1-CC) following cytidine to uridine (C-to-U) editing by AID remains undefined. To unveil this mechanism, we tested antisense oligonucleotides (ASOs) targeting noncoding germline transcripts (GLTs) that form R-loops across DNA cleavage sites during CSR. These studies revealed that the anti-GLT-ASOs increased DNA cleavage frequency, concomitant with a decrease in R-loops. Mechanistically, ASO-mediated R-loop disruption led to increased TOP1-CC formation specifically within the GLT region during CSR. Furthermore, an in vitro transcription assay demonstrated that RNase H-mediated R-loop degradation enhanced positive supercoiling and double-strand breaks in the presence of TOP1, even in the absence of AID. Moreover, knockout of Tyrosyl-DNA phosphodiesterase 1 ( Tdp1 ), a canonical TOP1-CC processing enzyme, revealed that TDP1 suppresses CSR, indicating that accumulated TOP1-CCs in Tdp1 knockout cells serve as substrates for CSR through an alternative TOP1-CC processing pathway. Collectively, these results suggest the R-loop destabilization as a critical, hitherto unrecognized intermediary step linking C-to-U editing to TOP1-CC formation. AID-mediated C-to-U editing within R-loops introduces a G:U wobble base pair, which we hypothesize renders R-loops unstable and sensitive to nuclear RNases, leading to R-loop disruption; this disruption consequently induces the TOP1-CCs and results in CSR, as confirmed in this study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Genomic Medicine, Center for Cancer Immunotherapy and Immunobiology, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan.
ORCID-Profile: Tasuku Honjo
Förderung
- MEXT | Japan Society for the Promotion of Science (JSPS)
Zitieren
APA
Kobayashi, M., Chen, X., & Honjo, T. (2026). R-loop disruption triggers irreversible topoisomerase 1–DNA cleavage complex formation during AID-dependent IgH gene diversification. Proceedings of the National Academy of Sciences, 123(14). https://doi.org/10.1073/pnas.2533648123
Vancouver
Kobayashi M, Chen X, Honjo T. R-loop disruption triggers irreversible topoisomerase 1–DNA cleavage complex formation during AID-dependent IgH gene diversification. Proceedings of the National Academy of Sciences. 2026;123(14). doi:10.1073/pnas.2533648123
BibTeX
@article{Kobayashi2026,
author = {Kobayashi, Maki and Chen, Xi and Honjo, Tasuku},
title = {R-loop disruption triggers irreversible topoisomerase 1–DNA cleavage complex formation during AID-dependent IgH gene diversification},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {14},
doi = {10.1073/pnas.2533648123}
}
EUVIMED